Shalparni

<h3> Absolute Contraindications of Shalparni </h3> <h4> Being treated with insulin or oral diabetes medicines (low blood sugar risk)</h4> <ul> <li> ⚠️ <li> Recommendation: If you already take insulin or blood-sugar lowering pills, do not start Shalparni without discussing dose changes with your prescriber-monitor blood sugar closely. <li> Reasoning: Animal and cell studies show Desmodium extracts lower blood glucose and stimulate insulin release; when combined with prescribed hypoglycemic drugs this can cause excessive lowering of blood glucose (hypoglycaemia). <li> Scientific_Study_Title: Effect of Desmodium gangeticum extract on blood glucose in rats and on insulin secretion in vitro <li> Scientific_Study_Authors: Raghavan Govindarajan, Henry Asare-Anane, Shanta Persaud, Peter Jones, Peter J Houghton <li> Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/17431824/ <li> Scientific_Study_Excerpt: <p>In diabetic rats treated orally with aerial parts extract of Desmodium gangeticum (100 and 250 mg/kg) for three weeks, investigators observed a statistically significant reduction in blood glucose compared with controls. Complementary in vitro work showed the extract increased insulin secretion from MIN6 pancreatic beta-cell models (monolayers and pseudoislets). The paper concludes the plant’s antidiabetic action is at least partly due to stimulation of insulin release and also produced favourable changes in lipid profile (reduced cholesterol and triglycerides, increased HDL). These findings support caution when combining the plant with hypoglycaemic drugs because additive glucose-lowering effects may occur.</p> </ul> <h4> Using sedatives, opioid pain medicines or other central nervous system depressants</h4> <ul> <li> 😴 <li> Recommendation: Avoid combining Shalparni extracts with sedatives, benzodiazepines, opioids or alcohol without medical advice; if you must combine, use lower doses and avoid driving/operating machinery. <li> Reasoning: Animal pharmacology shows moderate CNS-depressant effects (reduced locomotion, exploratory behaviour), so additive sedation or slowed reflexes can occur with other CNS depressants. <li> Scientific_Study_Title: The effects of aqueous extracts of Desmodium gangeticum DC. (Leguminosae) on the central nervous system <li> Scientific_Study_Authors: S Jabbar, M T Khan, M S Choudhuri <li> Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/11446174/ <li> Scientific_Study_Excerpt: <p>Rodent behavioural studies with aqueous Desmodium gangeticum extract showed no effect in a hot-plate analgesia test but pronounced activity in the acetic-acid writhing assay and moderate depression of central nervous system behaviours: spontaneous motor activity, hole-cross, open-field and hole-board tests were all reduced. The authors compared effects with standard CNS agents and concluded the extract exerts an observable CNS-depressant profile in vivo. Clinically, this implies potential additive sedation when used with other depressant drugs.</p> </ul> <h4> Pregnancy and breastfeeding (use with caution / avoid unless prescribed)</h4> <ul> <li> 🤰 <li> Recommendation: Avoid routine use of Shalparni extracts during pregnancy or breastfeeding unless a qualified practitioner has weighed benefits and risks; seek medical advice before use. <li> Reasoning: There are limited controlled human safety data for Desmodium species in pregnancy; general reviews of medicinal plant use in pregnancy document risks from untested herbs and recommend avoidance when safety is unproven. <li> Scientific_Study_Title: Is it safe to consume traditional medicinal plants during pregnancy? - a review of potential risks <li> Scientific_Study_Authors: (Review authors summarized in article) <li> Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/33164294/ <li> Scientific_Study_Excerpt: <p>Comprehensive reviews of traditional medicinal plant use in pregnancy highlight documented risks such as embryotoxicity, teratogenicity and uterine stimulation for certain herbs and emphasize that many plants lack adequate reproductive safety data. The authors stress that phytochemicals can cross the placenta and alter hormone balance or uterine activity, potentially causing miscarriage or fetal harm. Because specific reproductive safety trials are missing for many herbs (including many Desmodium spp.), the conservative recommendation is to avoid non-essential herbal medicines in pregnancy and lactation without specialist oversight.</p> </ul> <h3> Relative Contraindications of Shalparni </h3> <h4> Taking medicines primarily cleared by liver cytochrome P450 enzymes (narrow therapeutic index drugs)</h4> <ul> <li> 💊 <li> Interaction_Details: Shalparni relatives in the Desmodium genus have been shown in animal studies to alter hepatic drug-metabolising enzyme activity (induction/inhibition), which can change blood levels of co-administered drugs. <li> Severity: Moderate <li> Recommendation: If you take warfarin, anticonvulsants, oral contraceptives or other drugs with narrow therapeutic windows, consult your clinician before starting Shalparni; monitoring or dose adjustment may be needed. <li> Scientific_Study_Title: Acute and Subchronic Toxicity Studies of Aqueous Extract of Desmodium adscendens (Sw) DC <li> Scientific_Study_Authors: Osbourne Quaye, Precious Cramer, Mark Ofosuhene, Laud K N Okine, Alexander K Nyarko <li> Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/29228815/ <li> Scientific_Study_Excerpt: <p>Subchronic administration of Desmodium adscendens leaf extract in rats altered hepatic microsomal protein content and activities of CYP-linked enzyme assays (EROD, PROD and para-nitrophenol activities used as proxies for CYP1A, CYP2B and CYP2E systems). The same study observed a decrease in thiopentone sleeping time and altered zoxazolamine paralysis time, consistent with modulation of drug metabolism. The authors warned that such CYP induction/inhibition implies possible herb-drug interactions when extracts are co-administered with conventional drugs metabolised by these pathways.</p> </ul> <h4> Children, frail elderly or those with chronic multi-morbidity (limited human dose-finding and safety trials)</h4> <ul> <li> 👶🧓 <li> Recommendation: Use caution in very young children, frail elderly or medically complex patients - start with low exposures only under practitioner supervision and monitor clinically. <li> Reasoning: While several Desmodium species show pharmacological promise, controlled human dosing and long-term safety data are limited; animal acute toxicity and single-species reports are available but do not substitute for clinical trials in vulnerable groups. <li> Scientific_Study_Title: Methanol Leaf Extract of Desmodium velutinum (Wild.) D.C. and Acarbose Exhibit Additive Pharmacological Effects in Diabetic Wistar Rats <li> Scientific_Study_Authors: Ozougwu V E O, Akuba B O, Idakwoji P A <li> Scientific_Study_Link: https://biomedgrid.com/fulltext/volume14/methanol-leaf-extract-of-desmodium-velutinum-wild.d.c.and-acarbose-exhibit-additive-pharmacological-effects-in-diabetic-wistar-rats.001958.php <li> Scientific_Study_Excerpt: <p>Preclinical work with Desmodium velutinum showed glucose-lowering effects in diabetic rat models and reported acute toxicity testing to establish LD50 values; the paper concluded the extract and acarbose had additive pharmacological effects. The study underscores that most safety and dose-finding evidence for Desmodium spp. comes from animal models; human-specific dosing and long-term safety (particularly in infants, children and frail elders) remain insufficient, supporting a cautious approach in these groups.</p> </ul>